Advertisement

Topics

STAT Plus: Pharmalittle: FDA staff cautious on J&J arthritis drug; Kite seeks EU nod for CAR-T drug

09:26 EDT 1 Aug 2017 | STAT

An experimental Johnson & Johnson rheumatoid arthritis drug was linked to more deaths than placebo, FDA staff reviewers wrote in advance of a panel meeting.

Original Article: STAT Plus: Pharmalittle: FDA staff cautious on J&J arthritis drug; Kite seeks EU nod for CAR-T drug

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: FDA staff cautious on J&J arthritis drug; Kite seeks EU nod for CAR-T drug"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...